Postoperative radiotherapy remains controversial in non-small cell lung cancer. The conclusions of several meta-analysis are still questioned, partly because of flaws in the randomized trials taken into account.

The technological improvements of modern radiotherapy and several clinical observations have led to the launch of a new phase III trial.